Efgartigimod alfa. Neonatal Fc receptor (FcRn) antagonist, Treatment of generalized myasthenia gravis, Treatment of primary immune thrombocytopenia, Treatment of pemphigus vulgaris and foliaceous, Treatment of chronic inflammatory demyelinating polyneuropathy

2021 ◽  
Vol 46 (9) ◽  
pp. 691
Author(s):  
D. Ribeiro
Sign in / Sign up

Export Citation Format

Share Document